DEEP DIVE : Cardio-Renal-Metabolic Disease ( Leeds)

FACE TO FACE EVENT

THIS EVENT IS OPEN TO UK REGISTERED HEALTHCARE PROFESSIONALS ONLY

Location: The Queens Hotel ,City Square, Leeds, England, LS1 1PJ

Event Agenda

Learning outcomes

• Describe expanded approaches to chronic kidney disease management Evaluate the current 4 in 4 framework for CKD and assess the evidence for adopting a 5 in 5 approach in everyday primary care practice.
• Identify patients who may be undertreated for lipid-related cardiovascular risk Recognise gaps in current lipid management and apply evidence-based strategies to optimise treatment in high-risk groups within primary care.
• Apply updated NICE guidance (NG28) to diabetes management in primary care Critically appraise shifts in clinical practice for type 2 diabetes and translate contemporary guidance into safe, person-centred care decisions.
• Assess primary care's readiness to address the obesity epidemic Outline practical approaches to the recognition and management of obesity, and identify actionable steps to support patients from identification through to intervention.

Key benefits

• CPD-accredited, face-to-face learning
• Expert-led sessions with real-world case discussions
• Practical, evidence-based updates you can apply immediately
• NICE-aligned guidance translated into everyday clinical decisions
• Networking with fellow UK primary care professionals
• Engagement with expert faculty and industry partners

This study day is CPD-accredited. All attendees who participate in the full programme will receive a CPD certificate, supporting professional development and revalidation requirements across UK healthcare professions.

Meet the Speakers

Hannah Beba

Consultant Pharmacist for Diabetes. West Yorkshire & Leeds Health and Care Partnership. Co-Chair DUK Healthcare Prof Advisory Committee. PCDS committee member.

Hannah Beba is an RPS-approved Consultant Pharmacist at West Yorkshire Health and Care Partnership, working across the ICB and provider organisations to improve outcomes for people living with diabetes. Her role is primary care–focused and embedded in integrated care, with a strong emphasis on tackling health inequalities.Hannah chairs the Leeds and West Yorkshire Expert Reference Groups for Cardio-Renal-Metabolic Medicine and is the clinical lead for the obesity portfolio across the Partnership, driving a population health management approach. Nationally, she is co-chair of the Council of Healthcare Professionals at Diabetes UK and a committee member of the Primary Care Diabetes and Obesity Society.A clinical academic with a passion for education, Hannah speaks regularly at national conferences, tutors on the University of Warwick MSc Diabetes programme, and is currently an NIHR pre-doctoral fellow researching how to implement impactful renal care for people with diabetes in primary care.

Dr Waqas Tahir

MBBS, MRCGP, GP Partner Affinity Care (Willows Medical Centre) GPwER Diabetes and CVRM Diabetes Clinical Lead – Bradford System Programme Board West Yorkshire ICS Diabetes Clinical Lead Clinical Lead Diabetes & Obesity – NHSE NE&Y (RMT) PCDS

Dr Waqas Tahir is a practising general practitioner and partner in Affinity Care, a multi-site partnership covering 65,000 patients. He also works as a specialist GP in Diabetes and Cardiometabolic medicine, advising and teaching local GPs, nurses, and pharmacists. He has a particular interest in translating evidence into practice, multi-morbidity and the role of technology and innovation in the delivery of patient care. He is a standing member of the NICE Indicator Advisory Committee and a specialist committee member for NICE Quality Standards on T1 and T2 Diabetes. He is the ICS clinical diabetes lead for West Yorkshire Health and Care Partnership as well as the diabetes and obesity clinical lead for North East & Yorkshire regional medical team within the NHS. In these roles, he has taken an avid interest in reducing health inequalities and championing diabetes awareness and prevention across the region. More recently, he has joined the expert parliamentary working group to develop policy reforms that can help to improve outcomes for people living with diabetes across the UK and is a member of the council of healthcare professionals (CHP) for the charity Diabetes UK (DUK). He is a committee member for the PCDOS(UK) and the Vice President for the PCDE Education Committee. He has recently been elected to the Executive Board of PCDE(Europe).

Symposium Sponsor

Treatment For Prophylactic Management of Episodic Migraine This session was sponsored by AbbVie Ltd. The speaker’s session has been organised and funded by AbbVie, including payment of the speaker

Event Sponsors

This meeting has been organised by CliniLink Ltd and is supported by several pharmaceutical companies who have sponsored this event via the purchase of exhibition stand space. The sponsors A Menarini Farmaceutica Internazionale SRL, Abbott, Ascensia Diabetes Care, Daiichi Sankyo, Dexcom and Novo Nordisk were not involved in the development of the agenda and have had no influence over the agenda, the speakers or the content of the meeting.